Resistance and efficiency of amikacin in critically ill septic children: a cross-sectional study
Journal of Pediatric and Neonatal Individualized Medicine · 2026-04 · 15 (1) · e150112-e150112
DOI: 10.7363/150112 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Pediatric and Neonatal Individualized Medicine, 2026-04. Verfasst von Aya Osama Mohamed und 6 weiteren Autor:innen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Therapeutic drug monitoring facilitates the individualization of amikacin dosing for patients based on pharmacodynamics and pharmacokinetics. Its efficacy is measured by peak serum concentration (Cpeak) / minimum inhibitory concentration (MIC) ratio. This study aims to determine the efficacy of 15 mg/kg/day of amikacin in critically ill septic pediatric patients.
Methods
This cross-sectional analytic study involved 25 pediatric critically ill septic patients. All patients received amikacin based on clinical diagnosis and/or culture results. Amikacin Cpeak and MIC were measured.
Results
Amikacin Cpeak was not achieved in 44% of the study group, with the MIC being at least 64 mcg/mL, leading to a very low Cpeak/MIC ratio.
Conclusion
Critically ill pediatric patients who are administered amikacin require frequent monitoring and dose adjustment to achieve the target level, as subtherapeutic levels may contribute to resistance, while elevated levels are linked to non-oliguric acute kidney injury.
Schlagwörter
Zitieren
APA
Mohamed, A. O., Algebaly, H. F., Aziz, B. F., Mohamed, M. A., Srour, A. F., Aziz, M. M., & Megied, M. A. A. E. (2026). Resistance and efficiency of amikacin in critically ill septic children: a cross-sectional study. Journal of Pediatric and Neonatal Individualized Medicine, 15(1), e150112-e150112. https://doi.org/10.7363/150112
Vancouver
Mohamed AO, Algebaly HF, Aziz BF, Mohamed MA, Srour AF, Aziz MM, et al. Resistance and efficiency of amikacin in critically ill septic children: a cross-sectional study. Journal of Pediatric and Neonatal Individualized Medicine. 2026;15(1):e150112-e150112. doi:10.7363/150112
BibTeX
@article{Mohamed2026,
author = {Mohamed, Aya Osama and Algebaly, HebatAllah Fadel and Aziz, Bola Fathallah and Mohamed, May Abdelfattah and Srour, Amira Fathi and Aziz, Miriam Magdy and Megied, Mohamed Abdallah Abd El},
title = {Resistance and efficiency of amikacin in critically ill septic children: a cross-sectional study},
journal = {Journal of Pediatric and Neonatal Individualized Medicine},
year = {2026},
volume = {15},
number = {1},
pages = {e150112--e150112},
doi = {10.7363/150112}
}
EUVIMED